Literature DB >> 3492409

Regulation of androgen production by frog (Rana esculenta) testis: an in vitro study on the effects exerted by estradiol, 5 alpha-dihydrotestosterone, testosterone, melatonin, and serotonin.

R Pierantoni, B Varriale, S Minucci, L Di Matteo, S Fasano, M D'Antonio, G Chieffi.   

Abstract

The possible role of estradiol-17 beta (E2), testosterone (T), 5 alpha-dihydrotestosterone (DHT), melatonin, and serotonin on the regulation of androgen (A) production by the frog, Rana esculenta, testes was studied in vitro. E2 (10(-6) M) inhibited A production whether alone or in combination with oLH (20 micrograms) after 6 hr incubation. After 24 hr incubation. A production was reduced by E2 concentration of around 10(-6) and 10(-9) M. Melatonin and serotonin did not induce any change whichever experimental condition was used. Preincubation for 6 hr with 10(-6) M T or DHT enhanced the oLH-stimulated A production after 18 hr incubation. These data suggest that steroids may regulate their intratesticular levels without passing into the blood stream.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492409     DOI: 10.1016/0016-6480(86)90076-6

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  3 in total

1.  Dopamine regulation of testicular activity in intact and hypophysectomized frogs, Rana esculenta.

Authors:  S Minucci; S Fasano; M D'Antonio; R Pierantoni
Journal:  Experientia       Date:  1993-01-15

2.  Regulation of thyroid hormone-, oestrogen- and androgen-related genes by triiodothyronine in the brain of Silurana tropicalis.

Authors:  Paula Duarte-Guterman; Vance L Trudeau
Journal:  J Neuroendocrinol       Date:  2010-07-02       Impact factor: 3.627

3.  Alteration of the hypothalamic-pituitary-gonadal axis in estrogen- and androgen-treated adult male leopard frog, Rana pipiens.

Authors:  Pei-San Tsai; Ann E Kessler; Jeremy T Jones; Kathleen B Wahr
Journal:  Reprod Biol Endocrinol       Date:  2005-01-10       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.